Can new scans predict chemo success in tough breast cancer?

NCT ID NCT02744053

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 24 times

Summary

This early-phase study looks at whether special imaging scans (DCE-MRI and MBI) can predict how well chemotherapy works in people with triple negative breast cancer. About 96 participants will get these scans before, during, and after chemo to see if the images can tell who is responding. The goal is to find a better way to measure tumor shrinkage without relying only on surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

  • MD Anderson League City

    Nassau Bay, Texas, 77058, United States

  • MD Anderson in Katy

    Houston, Texas, 77094, United States

  • MD Anderson in Sugar Land

    Sugar Land, Texas, 77478, United States

  • MD Anderson in The Woodlands

    The Woodlands, Texas, 77384, United States

  • Memorial Hermann Memorial City Medical Center

    Houston, Texas, 77024, United States

Conditions

Explore the condition pages connected to this study.